PROF Profound Medical Corp.
Fundamentals / CIK 0001628808 / USDProfound Medical Corp. reported $23.63M in revenue and a net loss of $32.49M for the trailing twelve months ended September 30, 2026 (up 85.9% year over year), with a 73.9% gross margin and a -145.1% operating margin.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open PROF in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue TTM$23.63M +85.9% YoY
-
Operating Income TTM-$34.28M -145.1% margin
-
Net Income TTM-$32.49M -137.5% net margin
-
Diluted EPS TTM-$0.89 Split-adjusted
-
Free Cash Flow TTM-$38.38M -162.5% FCF margin
-
Cash & ST Investments Sep 30, 2026$33.34M Total debt: $7.36M
Annual revenue and net income
7 fiscal years (2019 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|
| Revenue | $16.10M | $10.68M | $7.20M | $6.68M | $6.87M | $7.30M | $4.17M |
| Cost of Revenue | $4.71M | $3.64M | $2.89M | $3.66M | $3.92M | $3.83M | $1.78M |
| Gross Profit | $11.39M | $7.04M | $4.31M | $3.02M | $2.95M | $3.47M | $2.39M |
| Research & Development | $20.60M | $16.96M | $14.42M | $14.69M | $15.28M | $9.91M | $9.40M |
| Selling, General & Admin | $32.05M | $23.13M | $18.54M | $17.93M | $17.97M | $12.43M | $7.90M |
| Total Operating Expenses | $52.65M | $40.10M | $32.96M | $35.15M | $33.24M | $22.34M | $17.29M |
| Operating Income | -$41.25M | -$33.06M | -$28.65M | -$32.13M | -$30.29M | -$18.86M | -$14.90M |
| EBITDA | -$40.69M | -$32.13M | -$27.72M | -$30.52M | -$28.41M | -$17.32M | -$13.39M |
| Interest Expense | $394K | $600K | $146K | $290K | $448K | $2.71M | $171K |
| Income Before Tax | -$42.32M | -$27.82M | -$28.45M | -$28.38M | -$30.59M | -$21.58M | -$15.07M |
| Income Tax Expense | $252K | -$2.0K | -$128K | $287K | $105K | $45K | $147K |
| Net Income | -$42.57M | -$27.82M | -$28.32M | -$28.67M | -$30.70M | -$21.62M | -$15.22M |
| Basic EPS | $1.41 | $1.12 | $1.34 | $1.38 | $1.50 | $1.25 | -- |
| Diluted EPS | $1.41 | $1.12 | $1.34 | $1.38 | $1.50 | $1.25 | -- |
| Basic Shares Outstanding | 30.2M | 24.8M | 21.2M | 20.8M | 20.5M | 17.3M | 11.1M |
| Diluted Shares Outstanding | 30.2M | 24.8M | 21.2M | 20.8M | 20.5M | 17.3M | 11.1M |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $9.83M | $2.48M | $5.34M | $5.98M | $5.29M | $2.21M | $2.62M | $4.18M |
| Cost of Revenue | $2.15M | $536K | $1.50M | $1.99M | $1.36M | $593K | $768K | $1.21M |
| Gross Profit | $7.68M | $1.95M | $3.83M | $3.99M | $3.93M | $1.62M | $1.85M | $2.96M |
| Research & Development | $5.81M | $5.65M | $5.26M | $4.27M | $5.42M | $6.10M | $4.81M | $4.65M |
| Selling, General & Admin | $9.70M | $7.36M | $6.59M | $7.09M | $7.43M | $9.33M | $8.21M | $6.66M |
| Total Operating Expenses | $15.50M | $13.01M | $11.85M | $11.36M | $12.84M | $15.42M | $13.02M | $11.31M |
| Operating Income | -$7.82M | -$11.07M | -$8.02M | -$7.37M | -$8.91M | -$13.81M | -$11.17M | -$8.35M |
| EBITDA | -$7.69M | -$10.93M | -$7.92M | -$7.26M | -$8.77M | -$13.66M | -$11.00M | -$8.11M |
| Interest Expense | $80K | $79K | $80K | $85K | $119K | $86K | $104K | -- |
| Income Before Tax | -$7.73M | -$9.48M | -$7.03M | -$8.15M | -$7.86M | -$15.63M | -$10.68M | -$5.18M |
| Income Tax Expense | -$4.0K | $55K | $25K | $26K | $121K | $64K | $41K | -$238K |
| Net Income | -$7.72M | -$9.54M | -$7.05M | -$8.18M | -$7.98M | -$15.70M | -$10.72M | -$4.95M |
| Basic EPS | -$0.21 | -$0.26 | $0.19 | -- | -$0.26 | -$0.52 | $0.36 | -- |
| Diluted EPS | -$0.21 | -$0.26 | $0.19 | -- | -$0.26 | -$0.52 | $0.36 | -- |
| Basic Shares Outstanding | 36.6M | 36.4M | 36.3M | -- | 30.1M | 30.1M | 30.0M | -- |
| Diluted Shares Outstanding | 36.6M | 36.4M | 36.3M | -- | 30.1M | 30.1M | 30.0M | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Jan 1 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $59.72M | $54.91M | $26.21M | $46.52M | $67.15M | $83.91M | $14.80M | $22.50M |
| Cash & Short-Term Investments | $59.72M | $54.91M | $26.21M | $46.52M | $67.15M | $83.91M | $14.80M | $22.50M |
| Accounts Receivable, Net | -- | -- | $6.75M | $5.84M | $1.41M | $7.43M | $3.12M | $1.97M |
| Inventory | $8.24M | $5.80M | $6.99M | $7.94M | $7.41M | $5.33M | $3.67M | $2.66M |
| Total Current Assets | $76.09M | $69.06M | $41.90M | $62.02M | $77.12M | $97.74M | $22.81M | $27.80M |
| Property, Plant & Equipment, Net | $698K | $425K | $909K | $899K | $788K | $859K | $527K | $885K |
| Goodwill | -- | -- | -- | -- | $2.69M | $2.68M | $2.62M | $2.50M |
| Intangible Assets | $138K | $261K | $490K | $680K | $1.44M | $1.90M | $2.41M | $2.94M |
| Total Non-Current Assets | $1.39M | $1.17M | $2.06M | $2.40M | $9.65M | $6.86M | $7.25M | $6.33M |
| Total Assets | $77.47M | $70.23M | $43.96M | $64.42M | $86.78M | $104.6M | $30.06M | $34.12M |
| Accounts Payable | $1.56M | $1.32M | $865K | -- | -- | -- | -- | -- |
| Short-Term Debt | -- | $1.74M | $2.10M | $523K | -- | -- | $3.96M | $982K |
| Deferred Revenue (Current) | $445K | $419K | $721K | -- | -- | $358K | $504K | $229K |
| Other Current Liabilities | $944K | $1.80M | $1.00M | -- | -- | $99K | $221K | $416K |
| Total Current Liabilities | $6.08M | $6.57M | $6.37M | $4.18M | $4.16M | $4.81M | $8.22M | $5.78M |
| Long-Term Debt | $4.50M | $2.92M | $5.00M | $6.65M | -- | -- | $5.17M | $7.78M |
| Deferred Revenue (Non-Current) | $388K | $49K | $728K | -- | -- | $1.08M | $639K | $278K |
| Other Non-Current Liabilities | $79K | $71K | $73K | -- | -- | -- | -- | $733K |
| Total Non-Current Liabilities | $4.97M | $3.25M | $6.36M | $8.23M | $2.00M | $2.44M | $7.46M | $8.83M |
| Total Liabilities | $11.04M | $9.81M | $12.73M | $12.42M | $6.16M | $7.25M | $15.69M | $14.61M |
| Total Debt (incl. Leases) | $4.71M | $5.12M | $7.87M | $8.23M | $1.38M | $1.68M | $10.97M | $8.76M |
| Common Stock | $323.8M | $281.6M | $222.2M | $205.8M | $219.6M | $211.5M | $100.3M | $88.65M |
| Retained Earnings | -$287.7M | -$245.2M | -$217.4M | -$189.4M | -$160.7M | -$130.0M | -$108.4M | -$93.27M |
| Accumulated Other Comp. Income | $5.03M | $2.74M | $5.57M | -- | -- | -- | -- | -- |
| Total Stockholders' Equity | $66.43M | $60.42M | $31.22M | $52.60M | $80.62M | $97.35M | $14.37M | $19.52M |
| Total Equity | $66.43M | $60.42M | $31.22M | $52.60M | $80.62M | $97.35M | $14.37M | $19.52M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $33.34M | $38.27M | $50.30M | $59.72M | $24.83M | $35.20M | $46.43M | $54.91M |
| Cash & Short-Term Investments | $33.34M | $38.27M | $50.30M | $59.72M | $24.83M | $35.20M | $46.43M | $54.91M |
| Inventory | $10.24M | $10.46M | $9.00M | $8.24M | $8.34M | $8.35M | $6.79M | $5.80M |
| Total Current Assets | $54.83M | $58.86M | $69.53M | $76.09M | $41.52M | $48.81M | $59.91M | $69.06M |
| Property, Plant & Equipment, Net | $430K | $556K | $682K | $698K | $338K | $278K | $309K | $425K |
| Intangible Assets | $115K | $121K | $129K | $138K | $123K | $175K | $214K | $261K |
| Total Non-Current Assets | $3.33M | $3.52M | $3.93M | $1.39M | $781K | $857K | $952K | $1.17M |
| Total Assets | $58.15M | $62.38M | $73.46M | $77.47M | $42.30M | $49.67M | $60.86M | $70.23M |
| Accounts Payable | $1.05M | $955K | $2.14M | $1.56M | $717K | $949K | $1.05M | $1.32M |
| Short-Term Debt | $4.51M | $4.51M | $4.50M | -- | $4.48M | -- | -- | $1.74M |
| Deferred Revenue (Current) | $805K | $342K | $464K | $445K | $434K | $694K | $636K | $419K |
| Other Current Liabilities | $1.46M | $996K | $1.02M | $944K | $630K | $509K | $955K | $1.80M |
| Total Current Liabilities | $12.06M | $9.11M | $10.61M | $6.08M | $9.94M | $5.72M | $5.29M | $6.57M |
| Long-Term Debt | $0 | $0 | $0 | $4.50M | $0 | $4.46M | $4.49M | $2.92M |
| Deferred Revenue (Non-Current) | $743K | $618K | $441K | $388K | $148K | $74K | $85K | $49K |
| Other Non-Current Liabilities | $93K | $92K | $92K | $79K | $76K | $77K | $72K | $71K |
| Total Non-Current Liabilities | $3.58M | $3.46M | $3.42M | $4.97M | $224K | $4.68M | $4.78M | $3.25M |
| Total Liabilities | $15.64M | $12.58M | $14.03M | $11.04M | $10.16M | $10.41M | $10.07M | $9.81M |
| Total Debt (incl. Leases) | $7.36M | $7.38M | $7.46M | $4.71M | $4.76M | $4.81M | $4.88M | $5.12M |
| Common Stock | $326.1M | $325.4M | $324.2M | $323.8M | $282.8M | $281.6M | $281.6M | $281.6M |
| Retained Earnings | -$312.1M | -$304.3M | -$294.8M | -$287.7M | -$279.6M | -$271.6M | -$255.9M | -$245.2M |
| Accumulated Other Comp. Income | $3.20M | $3.07M | $4.02M | $5.03M | $4.75M | $5.56M | $2.85M | $2.74M |
| Total Stockholders' Equity | $42.51M | $49.81M | $59.42M | $66.43M | $32.14M | $39.26M | $50.79M | $60.42M |
| Total Equity | $42.51M | $49.81M | $59.42M | $66.43M | $32.14M | $39.26M | $50.79M | $60.42M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|
| Net Income | -$42.57M | -$27.82M | -$28.32M | -$28.67M | -$30.70M | -$21.62M | -$15.22M |
| Depreciation & Amortization | $560K | $936K | $929K | $1.60M | $1.88M | $1.54M | $1.51M |
| Stock-Based Compensation | $5.49M | $2.58M | $3.42M | $4.24M | $7.21M | $3.02M | $1.27M |
| Change in Receivables | -- | -- | -$956K | -$1.42M | $2.00M | -$4.03M | -$1.03M |
| Change in Inventory | -$2.82M | $656K | $353K | -$1.86M | -$2.49M | -$2.14M | -$854K |
| Operating Cash Flow | -$38.21M | -$23.45M | -$22.61M | -$25.80M | -$22.36M | -$20.57M | -$15.05M |
| Capital Expenditure | -$176K | -- | -- | -- | -$32K | -- | -- |
| Free Cash Flow | -$38.38M | -- | -- | -- | -$22.39M | -- | -- |
| Investing Cash Flow | -$242K | -- | -- | -- | -$593K | -$350K | -$189K |
| Common Stock Issued | $42.44M | $62.11M | -- | -- | -- | $85.52M | $8.71M |
| Financing Cash Flow | $41.14M | $54.70M | $1.76M | $7.03M | $5.95M | $87.43M | $6.60M |
| Net Change in Cash | $2.69M | $31.24M | -$20.85M | -$18.77M | -$17.00M | $66.51M | -$8.64M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$7.72M | -$9.54M | -$7.05M | -$8.18M | -$7.98M | -$15.70M | -$10.72M | -$4.95M |
| Depreciation & Amortization | $133K | $135K | $100K | $109K | $147K | $141K | $163K | $238K |
| Stock-Based Compensation | $257K | $874K | $1.05M | $1.38M | $1.67M | $1.45M | $989K | $442K |
| Change in Inventory | $242K | -$1.69M | -$996K | -$229K | $130K | -$1.74M | -$984K | $480K |
| Operating Cash Flow | -$5.01M | -$11.34M | -$8.58M | -$6.57M | -$9.61M | -$13.74M | -$8.28M | -$5.88M |
| Common Stock Issued | -- | -- | -- | -- | -- | -- | -- | $39.17M |
| Financing Cash Flow | -- | -- | -- | $41.43M | $0 | $0 | -$290K | $35.44M |
| Net Change in Cash | -$4.97M | -$11.34M | -$8.58M | $34.62M | -$9.61M | -$13.74M | -$8.57M | $29.56M |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|
| Gross Margin | 70.8% | 65.9% | 59.9% | 45.2% | 43.0% | 47.6% | 57.3% |
| Operating Margin | -256.3% | -309.6% | -398.0% | -480.9% | -440.7% | -258.3% | -357.1% |
| Net Profit Margin | -264.4% | -260.4% | -393.4% | -429.1% | -446.7% | -296.0% | -364.7% |
| Return on Equity (ROE) | -64.1% | -46.0% | -90.7% | -54.5% | -38.1% | -22.2% | -105.9% |
| Return on Assets (ROA) | -54.9% | -39.6% | -64.4% | -44.5% | -35.4% | -20.7% | -50.6% |
| Current Ratio | 12.52x | 10.52x | 6.58x | 14.82x | 18.56x | 20.32x | 2.77x |
| Quick Ratio | 11.17x | 9.64x | 5.48x | 12.92x | 16.78x | 19.22x | 2.33x |
| Debt to Equity | 0.07x | 0.08x | 0.25x | 0.16x | 0.02x | 0.02x | 0.76x |
| Revenue Growth (YoY) | +50.7% | +48.4% | +7.8% | -2.8% | -5.9% | +75.0% | -- |
| Gross Profit Growth (YoY) | +61.9% | +63.2% | +42.7% | +2.3% | -15.0% | +45.4% | -- |
| EPS Growth (YoY) | +25.9% | -16.4% | -2.9% | -8.0% | +20.0% | -- | -- |
| 5Y Revenue / Share Growth | +26.1% | +14.7% | -- | -- | -- | -- | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 73.9% | 71.8% | 71.1% | 70.8% | 72.5% | 69.4% | 67.6% | 65.9% |
| Operating Margin | -145.1% | -185.3% | -202.6% | -256.3% | -295.4% | -357.4% | -306.4% | -309.6% |
| Net Profit Margin | -137.5% | -171.6% | -206.8% | -264.4% | -275.2% | -344.0% | -269.4% | -260.4% |
| Return on Equity (ROE) | -76.4% | -65.7% | -65.5% | -64.1% | -122.4% | -103.7% | -62.9% | -46.0% |
| Return on Assets (ROA) | -55.9% | -52.5% | -53.0% | -54.9% | -93.0% | -82.0% | -52.5% | -39.6% |
| Current Ratio | 4.54x | 6.46x | 6.56x | 12.52x | 4.18x | 8.53x | 11.31x | 10.52x |
| Quick Ratio | 3.70x | 5.31x | 5.71x | 11.17x | 3.34x | 7.07x | 10.03x | 9.64x |
| Debt to Equity | 0.17x | 0.15x | 0.13x | 0.07x | 0.15x | 0.12x | 0.10x | 0.08x |
| Revenue Growth (YoY) | +85.9% | +12.3% | +103.6% | +43.1% | +86.8% | -1.0% | +82.1% | -- |
| Gross Profit Growth (YoY) | +95.4% | +20.3% | +106.8% | +34.7% | +119.9% | +13.9% | +114.0% | -- |
| EPS Growth (YoY) | -- | -- | -47.2% | -- | -168.4% | -285.7% | +33.3% | -- |